Harry Keegan

Chief Executive Officer

Harry is a native of New England, graduated from Northeastern University school of business in 1992. Later he attended Suffolk University to get his Executive MBA. His primary focus has been in the medical /pharmaceutical industry with 30 years of his experience. Most of the experience came from working for Braintree Laboratories, a company focused on developing novel drugs in both gastroenterology and nephrology. There he worked as VP of Marketing and VP of Sales where he launched several successful drug launches where the products became market leaders. Later he worked in Business Development and eventually became CEO of the company. After the successful sale of the company in 2018 to Sebela Pharmaceuticals, he began to pursue several early stage/start up opportunities in the area of drug development and medical device innovation. Harry Keegan resides in Boston MA.

Rob Raleigh

Counsel and Co-Founder

Rob Raleigh resides in Massachusetts, and earned his MBA and JD from Suffolk University prior to kicking off a long career in the Pharmaceutical industry. He has worked to bring several products to market over the past 20 years while working closely with Harry Keegan at Braintree Laboratories. The primary focus of Braintree Laboratories during Rob’s tenure has been to develop new drugs and preparations for treatment of gastrointestinal diseases. Rob is a Co-Founder of BosTel Technologies, and takes an active role in defining the direction of product development.

Avi Dascalu

Chief Development Officer

Dr. Avi Dascalu is a world-renown Dermatologist practicing out of Tel- Aviv, Israel. After receiving his MD from Tel Aviv University Dr. Dascalu (Lt. Col. res., IDF) completed a PhD in Physiology and Pharmacology and has worked tirelessly to seek out innovative therapies and diagnostics to advance the field of Dermatology. He has been a key member of the Bostel development team, and has successfully demonstrated the clinical utility of the platform within formal research studies.

Will Cleveland

Clinical Development

Will grew up in New England, and is a UMASS alum with a bachelor’s in Microbiology. With over a decade in the Biotech industry, he has worked to support development of multiple groundbreaking products across a wide range of applications. His breadth of experience has ranged from development and manufacturing of bacteriophage-based environmental diagnostics to In-Vitro diagnostics and Cancer gene therapies. He is currently working to create highly accurate diagnostics and disease screening tools incorporating cutting-edge Machine Learning technology.

Ankur Kalra

Machine Learning Development

Ankur Kalra is the founder of Hop Labs, an artificial intelligence consultancy based out of Atlanta. Hop Labs focuses on production-scale machine learning solutions for real-world products, and works with both startups and established brands. Through its recent projects, Hop Labs has helped to fight cancer, empowered non-profit organizations around the world, streamlined aircraft maintenance, and has even made computers smart enough to help you find the best-fitting pair of pants. Through its work with BosTel, Hop Labs is helping to fight cancer with innovative computer vision and sonification technology.